Ciprofloxacin Reduces Occurrence of Fever in Children With Acute Leukemia who Develop Neutropenia During Chemotherapy

Abstract

Ciprofloxacin can prevent fever in neutropenic patients with acute lymphoblastic leukemia during the induction phase of chemotherapy with good tolerance and no serious side effects. Due to the selective pressure of intestinal flora resistance to ciprofloxacin, the long-term effectiveness needs further investigation.